Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Translating Promising Drug Candidates from Preclinical Screening to Clinical Trials
Translating Promising Drug Candidates from Preclinical Screening to Clinical Trials
SAN CARLOS, Calif., Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, today announced the presentation of new preclinical and clinical data for icovamenib
This drug may lower stroke risk in type 2 diabetes
This drug may lower stroke risk in type 2 diabetes
A new study has found that people with type 2 diabetes who take semaglutide may have a slightly lower risk
Aptevo announces addition of preclinical candidate APVO455 to portfolio
Aptevo announces addition of preclinical candidate APVO455 to portfolio
Aptevo Therapeutics (APVO) announced the addition of preclinical candidate APVO455
Boehringer’s Spevigo recommended by NICE for generalised pustular psoriasis
Boehringer’s Spevigo recommended by NICE for generalised pustular psoriasis
Boehringer Ingelheim’s Spevigo (spesolimab) has been recommended by the National Institute for Health and Care Excellence (NICE)
Novartis’ ribociclib approved in Canada for early breast cancer
Novartis’ ribociclib approved in Canada for early breast cancer
Health ribociclib Canada has granted a notice of compliance for Novartis Canada’s Kisqali (ribociclib tablets) plus an aromatase inhibitor for the adjuvant treatment of adults with stage II-...
BioAge Labs, Inc. Reports Promising Preclinical Results for APJ
BioAge Labs, Inc. Reports Promising Preclinical Results for APJ
BioAge Labs, Inc. Reports Promising Preclinical Results for APJ Agonist in Enhancing Glycemic Control and Cardioprotection in Diabetic Obesity and Heart Failure
US FDA approves Gilead's twice-yearly injection for HIV prevention
US FDA approves Gilead's twice-yearly injection for HIV prevention
June 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences, opens new tab lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and...
Telomir Pharmaceuticals reports positive results for progeria treatment
Telomir Pharmaceuticals reports positive results for progeria treatment
Telomir Pharmaceuticals , Inc. (NASDAQ:TELO) announced positive preclinical data for its lead candidate, Telomir-1, in human progeria cell lines.
Tisento’s MELAS treatment receives fast track status from FDA
Tisento’s MELAS treatment receives fast track status from FDA
Tisento Therapeutics has received fast track designation from the US Food and Drug Administration (FDA) for its investigational oral medicine, zagociguat, for mitochondrial encephalomyopathy
FDA Commissioner’s National Priority Vouchers Will Endanger Americans
FDA Commissioner’s National Priority Vouchers Will Endanger Americans
WASHINGTON, D.C. – The Food and Drug Administration (FDA) has announced a program that will shorten review times assessing safety and efficacy for some new drugs to one to two months.
Hoth Therapeutics reports positive preclinical safety data for HT-KIT
Hoth Therapeutics reports positive preclinical safety data for HT-KIT
NEW YORK - Hoth Therapeutics, Inc., a small-cap biotech company with a market capitalization of $17.17 million,
FDA to miss approval deadline for Kalvista drug due to ‘resource constraints’
FDA to miss approval deadline for Kalvista drug due to ‘resource constraints’
A “heavy workload” and “limited resources” have left the agency unable to meet a June 17 deadline to approve a therapy Kalvista has been developing for hereditary angioedema.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand